表紙:がん/腫瘍プロファイリングの世界市場:COVID-19影響分析、技術別、手法別、用途別の洞察、地域展望、競争戦略、セグメント別予測(~2027年)
市場調査レポート
商品コード
1070388

がん/腫瘍プロファイリングの世界市場:COVID-19影響分析、技術別、手法別、用途別の洞察、地域展望、競争戦略、セグメント別予測(~2027年)

Cancer/Tumor Profiling Market with COVID-19 Impact Analysis, By Technology, Technique, Application Insights - Regional Outlook, Competitive Strategies and Segment Forecasts to 2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 347 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
がん/腫瘍プロファイリングの世界市場:COVID-19影響分析、技術別、手法別、用途別の洞察、地域展望、競争戦略、セグメント別予測(~2027年)
出版日: 2022年03月01日
発行: AnalystView Market Insights
ページ情報: 英文 347 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん/腫瘍プロファイリングの市場規模は、2020年は79億610万米ドルで、予測期間中に20.2%のCAGRで拡大すると予測されています。

当レポートでは、世界のがん/腫瘍プロファイリング市場を調査しており、市場の概要、市場規模や予測、成長要因および抑制要因、技術・手法・用途・地域別の分析、さらにベンダー分析などを提供しています。

目次

第1章 がん/腫瘍プロファイリング市場の市場概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 技術別の市場内訳
    • 手法別の市場内訳
    • 用途別の市場内訳
    • 地域別の市場内訳
  • 競合考察

第3章 がん/腫瘍プロファイリングの主要市場動向

  • 市場促進要因
    • 市場促進要因の影響分析
  • 市場の抑制要因
    • 市場抑制要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 がん/腫瘍プロファイリング業界の調査

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析

第5章 がん/腫瘍プロファイリング市場:COVID-19影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析
    • 最高実績セグメント
    • 限界成長セグメント
    • 最大損失セグメント
    • 限界損失セグメント

第6章 がん/腫瘍プロファイリング市場情勢

  • 市場シェア分析(2019年)
  • 主要イノベーター分析
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 がん/腫瘍プロファイリング市場:技術別

  • 概要

第8章 がん/腫瘍プロファイリング市場:手法別

  • 概要

第9章 がん/腫瘍プロファイリング市場:用途別

  • 概要

第10章 がん/腫瘍プロファイリング市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東とアフリカ

第11章 ベンダー分析

  • 競争力のあるダッシュボード
  • 企業プロファイル
    • NeoGenomics Laboratories
    • Illumina
    • Helomics Corporation
    • HTG Molecular Diagnostics
    • Caris Life Sciences
    • Genomic Health
    • Ribomed Biotechnologies
    • NanoString Technologies
    • QIAGEN NV
    • Sysmex Corporation
    • Guardant Health
    • Roche Diagnostics

第12章 アナリストの全方位的展望

第13章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer/Tumor Profiling market: Technology Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Cancer/Tumor Profiling market, by Technology2016-2027 (USD Million)
  • TABLE Cancer/Tumor Profiling market: Technique Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Technique
  • TABLE Global Cancer/Tumor Profiling market, by Technique 2016-2027 (USD Million)
  • TABLE Cancer/Tumor Profiling market: Application Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer/Tumor Profiling market, by Application 2016-2027 (USD Million)
  • TABLE Cancer/Tumor Profiling market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer/Tumor Profiling market, by Region 2016-2027 (USD Million)
  • TABLE North America Cancer/Tumor Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE North America Cancer/Tumor Profiling market, by Technology, 2016-2027 (USD Million)
  • TABLE North America Cancer/Tumor Profiling market, by Technique, 2016-2027 (USD Million)
  • TABLE North America Cancer/Tumor Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Europe Cancer/Tumor Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Cancer/Tumor Profiling market, by Technology, 2016-2027 (USD Million)
  • TABLE Europe Cancer/Tumor Profiling market, by Technique, 2016-2027 (USD Million)
  • TABLE EuropeCancer/Tumor Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer/Tumor Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer/Tumor Profiling market, by Technology, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer/Tumor Profiling market, by Technique, 2016-2027 (USD Million)
  • TABLE Asia Pacific Cancer/Tumor Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Cancer/Tumor Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Cancer/Tumor Profiling market, by Technology, 2016-2027 (USD Million)
  • TABLE Latin America Cancer/Tumor Profiling market, by Technique, 2016-2027 (USD Million)
  • TABLE Latin America Cancer/Tumor Profiling market, by Application, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer/Tumor Profiling market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer/Tumor Profiling market, by Technology, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer/Tumor Profiling market, by Technique, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Cancer/Tumor Profiling market, by Application, 2016-2027 (USD Million)

List of Figures

  • FIGURE Cancer/Tumor Profiling market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Technology segment market share analysis, 2020 & 2027
  • FIGURE Technology segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Technique segment market share analysis, 2020 & 2027
  • FIGURE Technique segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Application segment market share analysis, 2020 & 2027
  • FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Cancer/Tumor Profiling market share and leading players, 2019
  • FIGURE Europe Cancer/Tumor Profiling market share and leading players, 2019
  • FIGURE Asia Pacific Cancer/Tumor Profiling market share and leading players, 2019
  • FIGURE Latin America Cancer/Tumor Profiling market share and leading players, 2019
  • FIGURE Middle East and Africa Cancer/Tumor Profiling market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Cancer/Tumor Profiling market share analysis by country, 2019
  • FIGURE Germany Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Cancer/Tumor Profiling market share analysis by country, 2019
  • FIGURE India Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Cancer/Tumor Profiling market share analysis by country, 2019
  • FIGURE Brazil Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Cancer/Tumor Profiling market share analysis by country, 2019
  • FIGURE Saudi Arabia Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Cancer/Tumor Profiling market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次
Product Code: ANV781

REPORT HIGHLIGHT

The Cancer/Tumor Profiling market is estimated to be worth US$ 7,906.1 million in 2020. Cancer/Tumor Profiling market is expected to expand at a 20.2% CAGR during the forecast period.

Market Introduction

Cancer/tumor profiling gives information on the genes that cause cancer, which can help researchers better understand how cancer works. Cancer profiling is helpful not just in the molecular diagnosis of common cancers like breast cancer and lymphoma, but also in the diagnosis of acute leukemia, prostate cancer, and lung cancer. Cancer profiling has become increasingly important in molecular diagnosis since a better understanding of cancer and tumors allows clinicians to make more informed therapeutic decisions and prevent over-treating cancer patients.

Market Dynamics

The growing demand of Oncologists for cancer profiling methods to diagnose or treat malignancies, as well as forecast response to targeted therapy, is driving the global market. In addition to this, an increase in the use of cancer biomarkers for tumor profiling, coupled with increasing incidences of cancer and an increase in the application of od sequencing techniques such as NGS techniques for cancer profiling also provide lucrative growth opportunities for global cancer/tumor profiling market. However, the growth of the global market is hampered by expensive monetary investments in biomarker research and a scarcity of experienced specialists or oncologists that specialize in tumor profiling. The pandemic had a relatively negative on the global market. Because of the COVID-19 outbreak, there has been a significant decline in cancer testing and detection due to coronavirus-related measures and resources. However, because of the high incidences of cancer in COVID-19 patients, cancer has been recognized as a high-risk factor for COVID-19. Further studies are being conducted in this area in order to better understand the dynamics of infection, which is likely to advance the cancer research sector. However, it is expected that majority of cancer diagnostic and prognostic tests, as well as tailored therapy, will rise at a steady rate over the next five years. Surgeries, chemotherapy rounds as well as radiation therapy have all been postponed significantly.

Segmentation Analysis

The Cancer/Tumor Profiling Market is segmented by technology, technique, application, regional distribution, and competitive landscape. Based on technique, the Genomics segment occupies the largest share, followed by Proteomics. The growing use of genomics for cancer diagnosis and prognosis, as well as in the biomarker development process, accounts for the largest share of this segment. The proteomic segment, on the other hand, is expected to witness a lucrative growth and rise at the fastest CAGR during the forecast period, owing to the growing use of proteomic methodologies for biomarker research in order to enhance the drug development process. They also demonstrate effectiveness in personalizing cancer treatment and monitoring. In addition to the growing pace of research and development on cancer biomarkers and advancements in technology also support the growth of the worldwide market.

Competitive Landscape

The global Cancer/Tumor Profiling market is highly competitive in nature and is dominated by a few local and international players. Major players in the industry engage in strategic mergers & acquisitions, partnerships, and new product launches to remain competent in the market. For instance, in March 2022, Illumina launched a new in vitro diagnostic test kit, TruSight Oncology Comprehensive test kit, in Europe that profiles cancer mutations and examines multiple cancer genes.

Key features of the study:

This proposed research study on Cancer/Tumor Profiling market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer/Tumor Profiling market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer/Tumor Profiling market.

Impact of COVID-19 on Cancer/Tumor Profiling market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer/Tumor Profiling market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Cancer/Tumor Profiling market, we have also included competitive landscape and key innovator analysis for the Cancer/Tumor Profiling market

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer/Tumor Profiling market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The Cancer/Tumor Profiling market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

Cancer/Tumor Profiling Market Key Players

NeoGenomics Laboratories

Illumina

Helomics Corporation

HTG Molecular Diagnostics

Caris Life Sciences

Genomic Health

Ribomed Biotechnologies

NanoString Technologies

QIAGEN N.V.

Sysmex Corporation

Guardant Health

Roche Diagnostics

Cancer/Tumor Profiling Market by Technology

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunoassays

Mass Spectrometry

In-Situ Hybridization

Microarrays

Others

Cancer/Tumor Profiling Market by Technique

Proteomics

Genomics

Metabolomics

Epigenetics

Cancer/Tumor Profiling Market by Application

Biomarker Discovery

Diagnostics

Prognostics

Personalized Medicine

Research Applications

Cancer/Tumor Profiling Market by Region

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle-East and Africa

GCC

South Africa

Rest of Middle-East and Africa

TABLE OF CONTENT

1. Cancer/Tumor Profiling Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Technology
    • 2.1.2. Market Snippet by Technique
    • 2.1.3. Market Snippet by Application
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer/Tumor Profiling Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Cancer/Tumor Profiling Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer/Tumor Profiling Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer/Tumor Profiling Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Cancer/Tumor Profiling Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2020 & 2027 (%)
    • 7.1.2. Next-Generation Sequencing (NGS)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Immunoassays
    • 7.1.5. Mass Spectrometry
    • 7.1.6. In-Situ Hybridization
    • 7.1.7. Microarrays
    • 7.1.8. Others

8. Cancer/Tumor Profiling Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2020 & 2027 (%)
    • 8.1.2. Proteomics
    • 8.1.3. Genomics
    • 8.1.4. Metabolomics
    • 8.1.5. Epigenetics

9. Cancer/Tumor Profiling Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
    • 9.1.2. Biomarker Discovery
    • 9.1.3. Diagnostics
    • 9.1.4. Prognostics
    • 9.1.5. Personalized Medicine
    • 9.1.6. Research Applications

10. Cancer/Tumor Profiling Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. U.S. Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.2. U.S. Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.3. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.2.8. Canada
      • 1.1.1.4. Overview
      • 1.1.1.5. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. Canada Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.2. Canada Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.3. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.7. Germany
      • 1.1.1.6. Overview
      • 1.1.1.7. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.8. Germany Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.9. Germany Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.10. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.8. Italy
      • 1.1.1.11. Overview
      • 1.1.1.12. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.13. Italy Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.14. Italy Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.15. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.9. United Kingdom
      • 1.1.1.16. Overview
      • 1.1.1.17. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.18. United Kingdom Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.19. United Kingdom Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.20. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.10. France
      • 1.1.1.21. Overview
      • 1.1.1.22. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.23. France Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.24. France Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.25. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.3.11. Rest of Europe
      • 1.1.1.26. Overview
      • 1.1.1.27. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.28. Rest of the Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.29. Rest of the Europe Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.30. Rest of the Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.7. India
      • 1.1.1.31. Overview
      • 1.1.1.32. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.33. India Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.34. India Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.35. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.8. China
      • 1.1.1.36. Overview
      • 1.1.1.37. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.38. China Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.39. China Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.40. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.9. Japan
      • 1.1.1.41. Overview
      • 1.1.1.42. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.43. Japan Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.44. Japan Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.45. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.10. South Korea
      • 1.1.1.46. Overview
      • 1.1.1.47. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.48. South Korea Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.49. South Korea Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.50. South Korea Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.4.11. Rest of APAC
      • 1.1.1.51. Overview
      • 1.1.1.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.53. Rest of APAC Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.54. Rest of APAC Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.55. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.5.7. Brazil
      • 1.1.1.56. Overview
      • 1.1.1.57. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.58. Brazil Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.59. Brazil Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.60. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.5.8. Mexico
      • 1.1.1.61. Overview
      • 1.1.1.62. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.63. Mexico Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.64. Mexico Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.65. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.5.9. Argentina
      • 1.1.1.66. Overview
      • 1.1.1.67. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.68. Argentina Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.69. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 1.1.1.70. Rest of LATAM Argentina Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.71. Overview
      • 1.1.1.72. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.73. Rest of LATAM Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.74. Rest of LATAM Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.75. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 1.1.1.76. Overview
      • 1.1.1.77. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.78. Saudi Arabia Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.79. Saudi Arabia Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.80. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 1.1.1.81. Overview
      • 1.1.1.82. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.83. United Arab Emirates Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
      • 1.1.1.84. United Arab Emirates Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
      • 1.1.1.85. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)

11. Key Vendor Analysis

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. NeoGenomics Laboratories
    • 11.2.2. Illumina
    • 11.2.3. Helomics Corporation
    • 11.2.4. HTG Molecular Diagnostics
    • 11.2.5. Caris Life Sciences
    • 11.2.6. Genomic Health
    • 11.2.7. Ribomed Biotechnologies
    • 11.2.8. NanoString Technologies
    • 11.2.9. QIAGEN N.V.
    • 11.2.10. Sysmex Corporation
    • 11.2.11. Guardant Health
    • 11.2.12. Roche Diagnostics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us